Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis

A significant proportion of patients with multiple sclerosis who receive interferon beta (IFNβ) therapy develop neutralizing antibodies (NAbs) that reduce drug efficacy. To investigate if HLA class I and II alleles are associated with development of NAbs against IFNβ we analyzed whether NAb status a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Link, Jenny, Lundkvist Ryner, Malin, Fink, Katharina, Hermanrud, Christina, Lima, Izaura, Brynedal, Boel, Kockum, Ingrid, Hillert, Jan, Fogdell-Hahn, Anna
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946519/
https://ncbi.nlm.nih.gov/pubmed/24608124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0090479
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires